CAP
Top Five Articles on 360Dx Last Week: Pfizer Shutting Down Lucira Health Business; More
Last week, readers were most interested in a story about Pfizer shuttering the Lucira Health business that it acquired in 2023.
College of American Pathologists Calls on HHS to End FDA Oversight of LDTs
CAP suggested in a letter to HHS that FDA regulation of LDTs conflicts with President Donald Trump's Jan. 31 executive order instructing agencies to reduce regulations.
Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing needs than it was during the COVID-19 pandemic.
Called the Coalition for Effective Diagnostics, the organization has called on lawmakers to pass legislation revamping diagnostics regulation, including oversight of LDTs.
CMS Final Pricing for Genomic Procedure Codes Leaves Lab, Industry Stakeholders Wanting More
Premium
After going through the gapfill process and releasing final pricing for six codes related to genomic sequencing procedures, the final pricing still has stakeholders worried.